Anti-tumor platinum(II) complexes and process for the preparatio

Organic compounds -- part of the class 532-570 series – Organic compounds – Heavy metal containing

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07F 1500

Patent

active

051420759

ABSTRACT:
The present invention relates to anti-tumor platinum complexes represented by the general formula I: ##STR1## wherein A is selected from the group consisting of ammine and mondentate primary alkyl- and cycloalkylamines having 1-3 carbon atoms such as methyl, ethyl, n-propyl-, isopropyl- and cyclopropylamines, or the two amine groups may be combined to be a bidentate diamine of the chelating form AA such as ethylenediamine, 1,2-diaminocyclohexane, and 2-hydroxy-1,3-diaminopropane, and X is either vinylene(--CH.dbd.CH--) or ethylene (--CH.sub.2 --CH.sub.2 --) when it is bound to two sulfur atoms in a cyclic form or represents two methyl groups separately bound to each sulfur atom.

REFERENCES:
patent: 4533502 (1985-08-01), Rochon et al.
patent: 4560782 (1985-12-01), Papageorgion et al.
patent: 4565884 (1986-01-01), Andrulis, Jr. et al.
patent: 4730069 (1988-03-01), Kolar et al.
patent: 4797393 (1989-01-01), Farrell et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Anti-tumor platinum(II) complexes and process for the preparatio does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-tumor platinum(II) complexes and process for the preparatio, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-tumor platinum(II) complexes and process for the preparatio will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-386281

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.